0000905718-19-000989.txt : 20191223
0000905718-19-000989.hdr.sgml : 20191223
20191223160513
ACCESSION NUMBER: 0000905718-19-000989
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191219
FILED AS OF DATE: 20191223
DATE AS OF CHANGE: 20191223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Muralidhar Bali
CENTRAL INDEX KEY: 0001784138
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39011
FILM NUMBER: 191306007
MAIL ADDRESS:
STREET 1: C/O EXICURE, INC.
STREET 2: 8045 LAMON AVENUE, SUITE 410
CITY: SKOKIE
STATE: IL
ZIP: 60077
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXICURE, INC.
CENTRAL INDEX KEY: 0001698530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815333008
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8045 LAMON AVE, SUITE 410
CITY: SKOKIE
STATE: IL
ZIP: 60077
BUSINESS PHONE: 847-673-1700
MAIL ADDRESS:
STREET 1: 8045 LAMON AVE, SUITE 410
CITY: SKOKIE
STATE: IL
ZIP: 60077
FORMER COMPANY:
FORMER CONFORMED NAME: Max-1 Acquisition Corp
DATE OF NAME CHANGE: 20170221
4
1
exicure_fm4dec192019.xml
X0306
4
2019-12-19
0
0001698530
EXICURE, INC.
XCUR
0001784138
Muralidhar Bali
C/O EXICURE, INC.
8045 LAMON AVENUE, SUITE 410
SKOKIE
IL
60077
1
0
0
0
Common Stock $0.0001 par value
2019-12-19
4
P
0
727000
2.75
A
6977000
I
See footnotes
The shares are held by Abingworth Bioventures VII LP ("Abingworth VII"). Abingworth Bioventures VII GP LP ("Abingworth GP") serves as the general partner of Abingworth VII. Abingworth General Partner VII LLP, serves as the general partner of Abingworth GP. Abingworth VII (acting by its general partner Abingworth GP, acting by its general partner Abingworth General Partner VII LLP) has delegated to Abingworth LLP ("ALLP"), all investment and dispositive power over the securities held by Abingworth VII. ALLP holds the reported securities indirectly through Abingworth VII. The reporting person is an employee of ALLP.
The reporting person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the reporting person or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
/s/ John Heard, as attorney-in-fact
2019-12-23